NIOSHTIC-2 Publications Search
Mechanisms of decaborane toxicity.
Toxicol Appl Pharmacol 1972 Aug; 22(4):517-527
In the presence of water, decaborane is rapidly transformed into one or more polar intermediate products that are eventually degraded to boric acid. The intermediate, but not decaborane or boric acid, reduces phosphomolybdic acid and inhibits glutamic-oxaloacetic transaminase. The inhibition of transaminase activity is kinetically irreversible when the ratio of apoenzyme to pyridoxal phosphate is kept constant, but is partially reversed when excess pyridoxal phosphate is added. The inhibitory activity disappears when the intermediate is neutralized with pyridoxal phosphate so that both the phosphomolybdate-reducing capacity of the intermediate and the spectral characteristics of the pyridoxal phosphate are abolished. Prior loading of mice with pyridoxine raises the LD50 of decaborane. It is concluded that toxicity of decaborane attendant upon inhibition of pyridoxal phosphate requiring enzymes is due not to decaborane per se, but to reduction of pyridoxal phosphate by a substance formed nonenzymically from decaborane in the presence of water.
NIOSH-Publication; NIOSH-Grant; Rocket-propellants; Central-nervous-system-disorders; Psychological-effects; Decarboxylases; Spectrophotometry; Thin-layer-chromatography; Absorption; PM9013643
Pharmacology and Therapeutics Univ of Florida Coll of Med Dept of Pharma & Therapeutics Gainesville, Fla 32601
1304-02-5; 10043-35-3; 54-47-7; 65-23-6
Issue of Publication
Toxicology and Applied Pharmacology
University of Florida Gainesville, Gainesville, Florida
Page last reviewed: April 12, 2019
Content source: National Institute for Occupational Safety and Health Education and Information Division